SEC 13F Intelligence

Polaris Capital Management, LLC / UTH

Polaris Capital Management, LLC’s United Therapeutics Corp Del Position

Does Polaris Capital Management, LLC own United Therapeutics Corp Del (UTH)? Yes — 96.7K shares worth $57M (+4.69% of its 13F portfolio) as of Q1 2026, down from 103.7K shares the prior filed quarter.

Position Value
$57M
Q1 2026
Shares
96.7K
% of Portfolio
+4.69%
Quarters Held
21
currently held

Position History UTH

Reported value by quarter
Q1 ’21: $72MQ1 ’21Q2 ’21: $69MQ3 ’21: $70MQ4 ’21: $81MQ4 ’21Q1 ’22: $64MQ2 ’22: $84MQ3 ’22: $72MQ3 ’22Q4 ’22: $89MQ1 ’23: $43MQ2 ’23: $43MQ2 ’23Q3 ’23: $30MQ4 ’23: $31MQ1 ’24: $30MQ1 ’24Q2 ’24: $47MQ3 ’24: $51MQ4 ’24: $47MQ4 ’24Q1 ’25: $42MQ2 ’25: $37MQ3 ’25: $51MQ3 ’25Q4 ’25: $51MQ1 ’26: $57Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202696.7K$57M+4.69%
Q4 2025103.7K$51M+4.19%
Q3 2025122.0K$51M+3.36%
Q2 2025127.7K$37M+2.44%
Q1 2025137.1K$42M+2.42%
Q4 2024131.8K$47M+2.24%
Q3 2024141.9K$51M+2.51%
Q2 2024148.6K$47M+2.54%
Q1 2024129.9K$30M+1.49%
Q4 2023142.6K$31M+1.51%
Q3 2023134.6K$30M+1.64%
Q2 2023193.2K$43M+1.60%
Q1 2023194.2K$43M+1.62%
Q4 2022321.4K$89M+3.11%
Q3 2022341.9K$72M+2.81%
Q2 2022366.0K$84M+1.47%
Q1 2022354.2K$64M+2.02%
Q4 2021374.8K$81M+2.61%
Q3 2021380.9K$70M+2.24%
Q2 2021382.1K$69M+2.21%
Q1 2021380.5K$72M+2.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Polaris Capital Management, LLC’s full portfolio or all institutional holders of UTH.